Skip to content

Constrained Balloon Combined With Drug-coated Balloon Angioplasty for Femoropopliteal Lesion

Constrained Balloon Combined With Drug-coated Balloon Angioplasty for Femoropopliteal Lesion: a Single-centre, Prospective Observational Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05894460
Enrollment
254
Registered
2023-06-08
Start date
2023-06-27
Completion date
2024-12-31
Last updated
2023-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Arterial Disease

Keywords

Femoral artery, Popliteal artery, Peripheral artery disease, Chocolate percutaneous transluminal angioplasty balloon, Drug-coated balloon

Brief summary

This study will assess the safety and efficacy of Chocolate balloons as a combination with drug-coated balloons in the treatment of popliteal artery lesions in lower limb atherosclerotic occlusive disease and will compare them with conventional balloons.

Interventions

Vascular preparation with chocolate balloons prior to drug-coated balloon angioplasty

Sponsors

Xuanwu Hospital, Beijing
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Rutherford classification of 2-6 in patients with femoropopliteal atherosclerotic occlusive disease; * primary cases with no previous surgical treatment of the target lesion; * presence of at least one vessel with patency in the distal outflow tract; * survival \>1 year.

Exclusion criteria

* planned stenting; * presence of flow-limiting dissection prior to application of Chocolate balloon and conventional balloon dilation of the target lesion; * combination of severe organ dysfunction of the heart, lungs and brain that cannot tolerate the procedure; * allergy to contrast agents, anaesthetic drugs, anticoagulants and anti-platelet drugs; * ineffective recanalization attempts; * lesions within or adjacent to the aneurysm, or the presence of a popliteal aneurysm.

Design outcomes

Primary

MeasureTime frameDescription
Primary patency12 monthsNo occlusion or restenosis (\>50%) of the target vessel in the treated segment during follow-up and no further intervention is required.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026